VAXALTA
VaxAlta is focused on developing sugar-based, effective, affordable, and easy to administer livestock vaccines that eliminate the use of antibiotics. VaxAlta also provides contract services to clients applying its proprietary platform technology toward the development of novel glycoconjugate vaccines against any pathogen (bacteria, virus, parasite, etc) where there is a unique glycan to target.
VAXALTA
Industry:
Health Care
Founded:
2013-01-01
Address:
Edmonton, Alberta, Canada
Country:
Canada
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Investors List
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Pre Seed Round - VaxAlta